Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Eric Aguiar
AddedApr 2, 2024
UpdatedMay 31, 2026
Eric Aguiar

Eric Aguiar

Board Member, Invitae

Crunchbase

Eric Aguiar's Career

Invitae
Invitae

San Francisco, CA, US

Board Member· Board
Garuda Therapeutics
Garuda Therapeutics

Cambridge, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Eric Aguiar's Career

Invitae
Invitae
Public$2.5B1.7k2010San Francisco, CA, US
Board Member· Board

Leadership at Invitae

Alex FurmanAlex FurmanCo-Founder
Geoffrey CrouseGeoffrey CrouseBoard Member
Randy ScottRandy ScottBoard Member
Kimber LockhartKimber LockhartBoard Member
Jason MyersJason MyersBoard Member
Christine GorjancChristine GorjancBoard Member

Similar to Invitae

23andMe23andMeSunnyvale, CA, USGenetic Testingest. 200623andMeSunnyvale, CA, US · est. 2006

23andMe: A biotech firm offering direct-to-consumer genetic testing for ancestry and health predispositions.

Public · $1.1B816
Fulgent GeneticsFulgent GeneticsTemple City, CA, USGenetic Testingest. 2011Fulgent GeneticsTemple City, CA, US · est. 2011

Fulgent Genetics, Inc.: A biotech firm offering advanced genetic testing via proprietary technology.

Public1k
GeneticaGeneticaSan Francisco, CA, USGene Testingest. 2017GeneticaSan Francisco, CA, US · est. 2017

San Francisco-based Genetica pioneers in gene testing technology for precision medicine in Asia.

Seed · $2.5M75
ColorColorBurlingame, CA, USGenetic Testing, Health Informationest. 2015ColorBurlingame, CA, US · est. 2015

Color: A health tech firm providing genetic tests for disease risk and medication response analysis.

Series E · $482M474
Garuda Therapeutics
Garuda Therapeutics
Series B$134M672021Cambridge, MA, US
Board Member· Board

Leadership at Garuda Therapeutics

Denise MoradDenise MoradCo-Founder
Steve LiapisSteve LiapisBoard Member
Laurence ReidLaurence ReidBoard Member
David ScaddenDavid ScaddenCo-Founder
Dhvanit ShahDhvanit ShahCo-Founder
Sean MorrisonSean MorrisonCo-Founder

Similar to Garuda Therapeutics

Guardian TherapeuticsGuardian TherapeuticsLexington, MA, USTherapeuticsest. 2017Guardian TherapeuticsLexington, MA, US · est. 2017

Guardian Therapeutics, pioneering the limitless potential of aptamer therapeutics.

Series B · $30M75
Stemson TherapeuticsStemson TherapeuticsSan Diego, CA, USCell Therapyest. 2018Stemson TherapeuticsSan Diego, CA, US · est. 2018

Stemson Therapeutics: Pioneering pre-clinical cell therapy for safe, natural hair restoration.

Series A · $22.5M36
APstem TherapeuticsAPstem TherapeuticsFremont, CA, USStem Cell Therapiesest. 2017APstem TherapeuticsFremont, CA, US · est. 2017

APstem Therapeutics: Advancing stem cell discoveries to combat diseases and aging challenges.

Seed · $4.3M6
Stemedica Cell TechnologiesStemedica Cell TechnologiesSan Diego, CA, USCell Therapy, Therapeuticsest. 2005Stemedica Cell TechnologiesSan Diego, CA, US · est. 2005

Stemedica Cell Technologies: Developing and commercializing cell and protein therapies for medical needs.

Series B · $67M175

Eric Aguiar's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Eric Aguiar

Ajay AgarwalAjay AgarwalBoard Member · ClockwiseRobert LongRobert LongBoard Member · Tavros TherapeuticsJohn HoJohn HoBoard Member · SolchromaMike McClureMike McClureBoard Member · AceableChris StallmanChris StallmanBoard Member · Karamba SecurityDavid AllisonDavid AllisonBoard Member · Neurogastrx